Literature DB >> 490559

Synthesis and antibacterial activity of 1-hydroxy-1-methyl-1,3-dihydrofuro[3,4-b]quinoxaline 4,9-dioxide and related compounds.

J P Dirlam, L J Czuba, B W Dominy, R B James, R M Pezzullo, J E Presslitz, W W Windisch.   

Abstract

A Free-Wilson analysis of the antibacterial activity found in a variety of quinoxaline 1,4-dioxides prepared and tested in these laboratories unexpectedly predicted that potent activity should be found in the case where the heterocyclic ring system was substituted with an acetyl group in the 2 position and a hydroxymethyl group in the 3 position (2). The synthesis and antibacterial activity of this compound, which was actually isolated in the hemiketal form (3), and of several of its derivatives are reported. 1-Hydroxy-1-methyl-1,3-dihydrofuro[3,4-b]quinoxaline 4,9-dioxide (3) possesses exceptional activity in vivo against Escherichia coli, Salmonella choleraesuis, and Pasteurella multocida.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 490559     DOI: 10.1021/jm00195a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  CP-82,996, a novel diglycoside polyether antibiotic related to monensin and produced by Actinomadura sp.

Authors:  J P Dirlam; A M Belton; J Bordner; W P Cullen; L H Huang; Y Kojima; H Maeda; S Nishiyama; J R Oscarson; A P Ricketts
Journal:  J Ind Microbiol       Date:  1990-10

2.  Additivity in the analysis and design of HIV protease inhibitors.

Authors:  Robert N Jorissen; G S Kiran Kumar Reddy; Akbar Ali; Michael D Altman; Sripriya Chellappan; Saima G Anjum; Bruce Tidor; Celia A Schiffer; Tariq M Rana; Michael K Gilson
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

3.  Unexpected reduction of ethyl 3-phenylquinoxaline-2- carboxylate 1,4-di-N-oxide derivatives by amines.

Authors:  Lidia M Lima; Esther Vicente; Beatriz Solano; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge
Journal:  Molecules       Date:  2008-01-17       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.